[Federal Register: September 27, 2007 (Volume 72, Number 187)]
[Notices]
[Page 54930]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27se07-79]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this
is notice that on August 30, 2007, Chattem Chemicals, Inc., 3801 St.
Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made
application by renewal to the Drug Enforcement Administration (DEA) for
registration as an importer of the basic classes of controlled
substances listed in schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methamphetamine (1105).....................  II
Phenylacetone (8501).......................  II
Raw Opium (9600)...........................  II
Concentrate of Poppy Straw (9670)..........  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances to
manufacture bulk controlled substances for sale to its customers.
    No comments, objections, or requests for any hearings will be
accepted on any application for registration or re-registration to
import crude opium, [Raw Opium (9600)], poppy straw, concentrate of
poppy straw, and coca leaves.
    Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances listed in schedule I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B) may, in the
circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR
1316.47.
    Any such comments or objections being sent via regular mail should
be addressed, in quintuplicate, to the Drug Enforcement Administration,
Office of Diversion Control, Federal Register Representative (ODL),
Washington, DC 20537, or any being sent via express mail should be sent
to Drug Enforcement Administration, Office of Diversion Control,
Federal Register Representative (ODL), 2401 Jefferson Davis Highway,
Alexandria, Virginia 22301; and must be filed no later than October 29,
2007.
    This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e) and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, (40 FR 43745-46), all
applicants for registration to import a basic class of any controlled
substances in schedule I or II are and will continue to be required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and
21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.

    Dated: September 21, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
 [FR Doc. E7-19100 Filed 9-26-07; 8:45 am]

BILLING CODE 4410-09-P